Yoga for improving thinking skills in people with unipolar depression

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether specific yoga practices can enhance cognitive abilities in individuals who have experienced unipolar depression and are currently in remission. It recognizes that cognitive deficits often persist even after depressive episodes have resolved, affecting executive functions such as decision-making and focus. Participants will engage in regular yoga sessions alongside their ongoing treatment for depression, with the aim of improving their cognitive performance. Screening for eligibility will involve a verbal questionnaire to assess symptoms and suitability for the study.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age more than 18years and less than 60 years
* H/o at least one depressive episode which is under remission and at the time of examination and throughout the study duration,
* Informed Consent

Exclusion Criteria:

* Comorbid Psychosis, OCD, Bipolar disorder
* Comorbid ADHD, IDD
* Comorbid substance dependence (except tobacco)
* Comorbid major or minor cognitive impairment,
* Bi temporal ECT within 6 months
* Past yoga practice - regularly for 1 month within 3 months Pregnancy

Where it's running

• National Institute of Mental Health and Neuroscience (NIMHANS)
  Bengaluru, Karnataka, India Recruiting

Study contacts

• Principal investigator: Vishwajit L Nimgaonkar, MD, PhD — University of Pittsburgh
• Study coordinator: Vishwajit L Nimgaonkar
• Email: vishwajitnl@upmc.edu
• Phone: 4127265164

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• RNA editing to predict antidepressant response in unipolar and bipolar depression

  This project tests whether changes in RNA editing can predict how adults with unipolar or bipolar depression respond to antidepressant treatment.

  Recruiting Phase 4 Mayo Clinic · Rochester, Minnesota · NCT07266545

• Psilocybin-assisted therapy for major depression in people with non-small cell lung cancer

  This phase II trial tests whether a single oral dose of psilocybin combined with psychotherapy can reduce moderate-to-severe depression in adults with non-small cell lung cancer.

  Recruiting Phase 2 Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07216404

• Transcranial direct current stimulation plus mindfulness for unipolar depression

  This project will test whether adding transcranial direct current stimulation (tDCS) to remotely delivered mindfulness helps adults with unipolar depression feel less depressed.

  Recruiting Soterix Medical · Woodbridge, New Jersey · NCT07042217

• EmoDTx mood-monitoring app for adults with unipolar depression

  This project will test whether the EmoDTx app, which analyzes facial expressions, can track mood in adults with unipolar depression and align with standard questionnaires.

  Recruiting at 2 sites Emobot · Changé, France and 1 other locations · NCT06860165

• Effects of theta burst stimulation on sleep and fatigue in depression

  This study is testing if two types of brain stimulation can improve sleep and reduce tiredness in people with depression.

  Recruiting Jagiellonian University · Warsaw · NCT06371352

• Using rTMS to treat mood and cognitive symptoms of depression

  This study is testing if a new way of using brain stimulation can help improve mood and thinking problems in people with unipolar and bipolar depression who haven't found relief from regular treatments.

  Recruiting Jagiellonian University · Krakow · NCT06363981

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.